Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132


Modelling Forward Osmosis Treatment of Automobile Wastewaters.

Haupt A, Marx C, Lerch A.

Membranes (Basel). 2019 Aug 22;9(9). pii: E106. doi: 10.3390/membranes9090106.


Synthesis and Photodimerization of 2- and 2,3-Disubstituted Anthracenes: Influence of Steric Interactions and London Dispersion on Diastereoselectivity.

Geiger T, Haupt A, Maichle-Mössmer C, Schrenk C, Schnepf A, Bettinger HF.

J Org Chem. 2019 Aug 16;84(16):10120-10135. doi: 10.1021/acs.joc.9b01317. Epub 2019 Aug 7.


Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial.

Giorgino F, Yu M, Haupt A, Milicevic Z, García-Pérez LE.

Diabetes Obes Metab. 2019 Jul 31. doi: 10.1111/dom.13844. [Epub ahead of print]


Fluorescent Gene Tagging of Transcriptionally Silent Genes in hiPSCs.

Roberts B, Hendershott MC, Arakaki J, Gerbin KA, Malik H, Nelson A, Gehring J, Hookway C, Ludmann SA, Yang R, Haupt A, Grancharova T, Valencia V, Fuqua MA, Tucker A, Rafelski SM, Gunawardane RN.

Stem Cell Reports. 2019 May 14;12(5):1145-1158. doi: 10.1016/j.stemcr.2019.03.001. Epub 2019 Apr 4.


LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.

Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, D'Alessio DA, Haupt A.

Mol Metab. 2018 Dec;18:3-14. doi: 10.1016/j.molmet.2018.09.009. Epub 2018 Oct 3.


A Positive Feedback between Growth and Polarity Provides Directional Persistency and Flexibility to the Process of Tip Growth.

Haupt A, Ershov D, Minc N.

Curr Biol. 2018 Oct 22;28(20):3342-3351.e3. doi: 10.1016/j.cub.2018.09.022. Epub 2018 Oct 11.


Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.

Frias JP, Nauck MA, Van J, Kutner ME, Cui X, Benson C, Urva S, Gimeno RE, Milicevic Z, Robins D, Haupt A.

Lancet. 2018 Nov 17;392(10160):2180-2193. doi: 10.1016/S0140-6736(18)32260-8. Epub 2018 Oct 4.


Corannulenes with Electron-Withdrawing Substituents: Synthetic Approaches and Resulting Structural and Electronic Properties.

Haupt A, Lentz D.

Chemistry. 2019 Mar 7;25(14):3440-3454. doi: 10.1002/chem.201803927. Epub 2018 Dec 13. Review.


Tuning the Electron Affinity and Stacking Properties of Corannulene by Introduction of Fluorinated Thioethers.

Haupt A, Lentz D.

Chem Asian J. 2018 Oct 18;13(20):3022-3026. doi: 10.1002/asia.201801311. Epub 2018 Sep 24.


Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.

Haupt A, Grancharova T, Arakaki J, Fuqua MA, Roberts B, Gunawardane RN.

J Vis Exp. 2018 Aug 25;(138). doi: 10.3791/58130.


Forward Osmosis Application in Manufacturing Industries: A Short Review.

Haupt A, Lerch A.

Membranes (Basel). 2018 Jul 23;8(3). pii: E47. doi: 10.3390/membranes8030047. Review.


Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.

Cusi K, Sattar N, García-Pérez LE, Pavo I, Yu M, Robertson KE, Karanikas CA, Haupt A.

Diabet Med. 2018 Oct;35(10):1434-1439. doi: 10.1111/dme.13697. Epub 2018 Jun 22.


Human impacts decouple a fundamental ecological relationship-The positive association between host diversity and parasite diversity.

Wood CL, Zgliczynski BJ, Haupt AJ, Guerra AS, Micheli F, Sandin SA.

Glob Chang Biol. 2018 Aug;24(8):3666-3679. doi: 10.1111/gcb.14159. Epub 2018 May 20.


Selective Synthesis of Perfluoroalkylated Corannulenes and Investigation of their Structural, Dynamic and Electrochemical Behavior.

Haupt A, Keller LM, Kutter M, Lentz D.

Chemistry. 2018 Jul 25;24(42):10756-10765. doi: 10.1002/chem.201801021. Epub 2018 Jun 27.


Mechanosensation Dynamically Coordinates Polar Growth and Cell Wall Assembly to Promote Cell Survival.

Davì V, Tanimoto H, Ershov D, Haupt A, De Belly H, Le Borgne R, Couturier E, Boudaoud A, Minc N.

Dev Cell. 2018 Apr 23;45(2):170-182.e7. doi: 10.1016/j.devcel.2018.03.022.


Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme.

Mathieu C, Del Prato S, Botros FT, Thieu VT, Pavo I, Jia N, Haupt A, Karanikas CA, García-Pérez LE.

Diabetes Obes Metab. 2018 Aug;20(8):2023-2028. doi: 10.1111/dom.13313. Epub 2018 May 2.


How cells sense their own shape - mechanisms to probe cell geometry and their implications in cellular organization and function.

Haupt A, Minc N.

J Cell Sci. 2018 Mar 26;131(6). pii: jcs214015. doi: 10.1242/jcs.214015. Review.


Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population.

Boye KS, Botros FT, Haupt A, Woodward B, Lage MJ.

Diabetes Ther. 2018 Apr;9(2):637-650. doi: 10.1007/s13300-018-0377-5. Epub 2018 Feb 19.


Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes.

Simeone JC, Bae JP, Hoogwerf BJ, Li Q, Haupt A, Ali AK, Boardman MK, Nordstrom BL.

Clin Epidemiol. 2017 Dec 14;9:679-688. doi: 10.2147/CLEP.S144368. eCollection 2017.


Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins.

Sanyal A, Cusi K, Hartman ML, Zhang S, Bastyr EJ 3rd, Bue-Valleskey JM, Chang AM, Haupt A, Jacober SJ, Konrad RJ, Zhang Q, Hoogwerf BJ.

J Investig Med. 2018 Mar;66(3):661-668. doi: 10.1136/jim-2017-000609. Epub 2017 Nov 21.


The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.

Pillai S, Duvvuru S, Bhatnagar P, Foster W, Farmen M, Shankar S, Harris C, Bastyr E 3rd, Hoogwerf B, Haupt A.

Pharmacogenomics J. 2018 May 22;18(3):487-493. doi: 10.1038/tpj.2017.45. Epub 2017 Nov 21.


Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization.

Roberts B, Haupt A, Tucker A, Grancharova T, Arakaki J, Fuqua MA, Nelson A, Hookway C, Ludmann SA, Mueller IA, Yang R, Horwitz R, Rafelski SM, Gunawardane RN.

Mol Biol Cell. 2017 Oct 15;28(21):2854-2874. doi: 10.1091/mbc.E17-03-0209. Epub 2017 Aug 16.


Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.

Cusi K, Sanyal AJ, Zhang S, Hartman ML, Bue-Valleskey JM, Hoogwerf BJ, Haupt A.

Diabetes Obes Metab. 2017 Nov;19(11):1630-1634. doi: 10.1111/dom.12973. Epub 2017 Jun 22.


Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015.

Meropol SB, Haupt AA, Debanne SM.

J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):36-45. doi: 10.1093/jpids/piw093.


Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes.

Zimdahl H, Haupt A, Brendel M, Bour L, Machicao F, Salsali A, Broedl UC, Woerle HJ, Häring HU, Staiger H.

Pharmacogenet Genomics. 2017 Apr;27(4):135-142. doi: 10.1097/FPC.0000000000000268.


Gradients of phosphatidylserine contribute to plasma membrane charge localization and cell polarity in fission yeast.

Haupt A, Minc N.

Mol Biol Cell. 2017 Jan 1;28(1):210-220. doi: 10.1091/mbc.E16-06-0353. Epub 2016 Nov 16.


Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action.

Jacober SJ, Prince MJ, Beals JM, Hartman ML, Qu Y, Linnebjerg H, Garhyan P, Haupt A.

Diabetes Obes Metab. 2016 Oct;18 Suppl 2:3-16. doi: 10.1111/dom.12744. Review.


Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.

Cusi K, Sanyal AJ, Zhang S, Hoogwerf BJ, Chang AM, Jacober SJ, Bue-Valleskey JM, Higdon AN, Bastyr EJ 3rd, Haupt A, Hartman ML.

Diabetes Obes Metab. 2016 Oct;18 Suppl 2:50-58. doi: 10.1111/dom.12751.


Cryo-slicing Blue Native-Mass Spectrometry (csBN-MS), a Novel Technology for High Resolution Complexome Profiling.

Müller CS, Bildl W, Haupt A, Ellenrieder L, Becker T, Hunte C, Fakler B, Schulte U.

Mol Cell Proteomics. 2016 Feb;15(2):669-81. doi: 10.1074/mcp.M115.054080. Epub 2015 Nov 23.


Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease.

Wicke K, Haupt A, Bespalov A.

Expert Opin Investig Drugs. 2015;24(12):1515-28. doi: 10.1517/13543784.2015.1102884. Epub 2015 Nov 7. Review.


Actin-Based Transport Adapts Polarity Domain Size to Local Cellular Curvature.

Bonazzi D, Haupt A, Tanimoto H, Delacour D, Salort D, Minc N.

Curr Biol. 2015 Oct 19;25(20):2677-83. doi: 10.1016/j.cub.2015.08.046. Epub 2015 Oct 1.


Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?

Schloot NC, Haupt A, Schütt M, Badenhoop K, Laimer M, Nicolay C, Reaney M, Fink K, Holl RW.

Diabetes Metab Res Rev. 2016 Mar;32(3):316-24. doi: 10.1002/dmrr.2722. Epub 2015 Nov 20.


Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.

Anderson EM, Haupt A, Schiel JA, Chou E, Machado HB, Strezoska Ž, Lenger S, McClelland S, Birmingham A, Vermeulen A, Smith Av.

J Biotechnol. 2015 Oct 10;211:56-65. doi: 10.1016/j.jbiotec.2015.06.427. Epub 2015 Jul 17.


Electrochemical regulation of budding yeast polarity.

Haupt A, Campetelli A, Bonazzi D, Piel M, Chang F, Minc N.

PLoS Biol. 2014 Dec 30;12(12):e1002029. doi: 10.1371/journal.pbio.1002029. eCollection 2014 Dec.


Regional diversity and developmental dynamics of the AMPA-receptor proteome in the mammalian brain.

Schwenk J, Baehrens D, Haupt A, Bildl W, Boudkkazi S, Roeper J, Fakler B, Schulte U.

Neuron. 2014 Oct 1;84(1):41-54. doi: 10.1016/j.neuron.2014.08.044. Epub 2014 Sep 18.


Macro- and microvascular outcomes in patients with type 2 diabetes treated with rapid-acting insulin analogues or human regular insulin: a retrospective database analysis.

Rathmann W, Schloot NC, Kostev K, Reaney M, Zagar AJ, Haupt A.

Exp Clin Endocrinol Diabetes. 2014 Feb;122(2):92-9. doi: 10.1055/s-0033-1363684. Epub 2014 Feb 20.


Dispersal at a snail's pace: historical processes affect contemporary genetic structure in the exploited wavy top snail (Megastraea undosa).

Haupt AJ, Micheli F, Palumbi SR.

J Hered. 2013 May-Jun;104(3):327-40. doi: 10.1093/jhered/est002. Epub 2013 Feb 28.


Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies.

Forst T, Hanefeld M, Jacob S, Moeser G, Schwenk G, Pfützner A, Haupt A.

Diab Vasc Dis Res. 2013 Jul;10(4):302-14. doi: 10.1177/1479164112465442. Epub 2013 Jan 4. Review.


Clinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE.

Liebl A, Jones S, Goday A, Benroubi M, Castell C, Haupt A, Nicolay C, Smith HT.

Diabetes Ther. 2012 Nov;3(1):9. doi: 10.1007/s13300-012-0009-4. Epub 2012 Aug 28.


Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics.

Haupt A, Joberty G, Bantscheff M, Fröhlich H, Stehr H, Schweiger MR, Fischer A, Kerick M, Boerno ST, Dahl A, Lappe M, Lehrach H, Gonzalez C, Drewes G, Lange BM.

BMC Cancer. 2012 Jan 25;12:38. doi: 10.1186/1471-2407-12-38.


Extending the dynamic range of label-free mass spectrometric quantification of affinity purifications.

Bildl W, Haupt A, Müller CS, Biniossek ML, Thumfart JO, Hüber B, Fakler B, Schulte U.

Mol Cell Proteomics. 2012 Feb;11(2):M111.007955. doi: 10.1074/mcp.M111.007955. Epub 2011 Nov 8.


An Obesity Risk SNP (rs17782313) near the MC4R Gene Is Associated with Cerebrocortical Insulin Resistance in Humans.

Tschritter O, Haupt A, Preissl H, Ketterer C, Hennige AM, Sartorius T, Machicao F, Fritsche A, Häring HU.

J Obes. 2011;2011:283153. doi: 10.1155/2011/283153. Epub 2011 Jun 3.


50 ways to improve your life in 2011: your mind.

Landau MD, Huey-Burns C, Rettig J, Terrell K, Kim MJ, Rubin C, Morella M, Haupt A.

US News World Rep. 2010 Dec;147(11):57-8, 60-4. No abstract available.


50 ways to improve your life in 2011: your health.

Haupt A, Burnsed B, Rubin C, Hobson K.

US News World Rep. 2010 Dec;147(11):16, 19-20, 22, passim. No abstract available.


Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et al.

Gallwitz B, Haupt A, Kraus P, Peters N, Petto H, Dotta F, Petto H, Poll L, Rose L, Schernthaner G.

Diabetes Obes Metab. 2010 Dec;12(12):1127-8. doi: 10.1111/j.1463-1326.2010.01309.x. No abstract available.


Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.

Banasikowski TJ, Bespalov A, Drescher K, Behl B, Unger L, Haupt A, Schoemaker H, Sullivan JP, Gross G, Beninger RJ.

J Pharmacol Exp Ther. 2010 Nov;335(2):506-15. doi: 10.1124/jpet.110.171348. Epub 2010 Aug 19.


Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain.

Müller CS, Haupt A, Bildl W, Schindler J, Knaus HG, Meissner M, Rammner B, Striessnig J, Flockerzi V, Fakler B, Schulte U.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):14950-7. doi: 10.1073/pnas.1005940107. Epub 2010 Jul 28.

Supplemental Content

Support Center